Acro Biomedical (ACBM) Enterprise Value (2016 - 2025)
Acro Biomedical (ACBM) has 10 years of Enterprise Value data on record, last reported at -$4098.0 in Q4 2025.
- For Q4 2025, Enterprise Value fell 760.92% year-over-year to -$4098.0; the TTM value through Dec 2025 reached -$4098.0, down 760.92%, while the annual FY2025 figure was -$4098.0, 760.92% down from the prior year.
- Enterprise Value reached -$4098.0 in Q4 2025 per ACBM's latest filing, up from -$4323.0 in the prior quarter.
- Across five years, Enterprise Value topped out at -$26.0 in Q2 2025 and bottomed at -$357668.0 in Q1 2022.
- Average Enterprise Value over 5 years is -$45593.5, with a median of -$5202.0 recorded in 2022.
- Peak YoY movement for Enterprise Value: plummeted 99042.95% in 2021, then soared 98.73% in 2023.
- A 5-year view of Enterprise Value shows it stood at -$95248.0 in 2021, then skyrocketed by 93.86% to -$5852.0 in 2022, then soared by 93.57% to -$376.0 in 2023, then decreased by 26.6% to -$476.0 in 2024, then crashed by 760.92% to -$4098.0 in 2025.
- Per Business Quant database, its latest 3 readings for Enterprise Value were -$4098.0 in Q4 2025, -$4323.0 in Q3 2025, and -$26.0 in Q2 2025.